aXichem updates the status of its application for Feed Additive approval for aXiphen in the EU
aXichem AB (publ), which develops and markets natural analogue industrial chemicals, announces that the company’s application for Feed Additive approval in the EU will be on the agenda at the plenary meeting of the FEEDAP panel on 26–28 September 2023 at the European Food Safety Authority (EFSA). The agenda for the meeting is published in the Open EFSA portal.
"I’m pleased to announce that aXichem is moving forward in the approval process. We have received a confirmation that our application will be on the agenda at the September meeting of the FEEDAP panel. In this meeting EFSAs scientific output is adopted, which is the final step in the risk assessment phase, and after which the scientific output can be published”, says Torsten Helsing, CEO of aXichem.
About FEEDAP
The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) provides scientific advice on the safety and/or efficacy of additives and products or substances used in animal feed. The Panel evaluates their safety and/or efficacy for the target species, the user, the consumer of products of animal origin and the environment.
About phenylcapsaicin and aXiphen
The health benefits of chili, with its active ingredient capsaicin have been known for centuries. aXichem’s proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, bridged by a triple bond. The result is an innovative natural analogue capsaicin with high purity, where the pungency is greatly reduced.
Production tests and studies have proven the effectiveness of aXiphen® as an ingredient in poultry feed. A production test on on-floor salmonella prevalence, following the inclusion of 15 ppm phenylcapsaicin in a regular starter diet, was carried out in a full-scale commercial broiler production trial under farming conditions. The production test included about 1.6 million broiler chickens. The trial concluded that under the conditions of the test, the inclusion of 15 ppm phenylcapsaicin in broiler chicken feed statistically significantly reduced the number of farms with salmonella-positive floor boot swabs. The European model for production efficiency, EPEF, showed that breeding efficiency increased by 14% compared to traditional feeding.
This information is such that aXichem AB is obliged to publish in accordance with the EU Market Abuse Regulation. The information was submitted, through the care of the contact person below, for publication on 19 September 2023, at 11:00 CET.
Torsten Helsing, CEO, aXichem, Ph+46 70 686 33 55. Email: torsten.helsing@axichem.se
About aXichem
aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Västra Hamnen Corporate Finance AB is Certified Adviser. More information is available at www.axichem.com.